HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c-myc suppression by interferon-gamma in situ.

Abstract
Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients, although the precise mechanism is controversial. From an immunological point of view, HLA-DR antigen, induced by interferon (IFN)-gamma, is required for tumor-associated antigen recognition by CD4(+) T cells. For instance, as reported previously, the expression of HLA-DR antigen in normal colorectal epithelium immediately adjacent to cancer coincided significantly with the existence of IFN-gamma mRNA in the tissue. From another aspect, IFN-gamma has been revealed to suppress c-myc expression in vivo through a stat1-dependent mechanism, which is important for cell growth, cell cycle and chromosome instability. In the present study, strong HLA-DR-positive expression on cancer cells was significantly related to better prognosis for colorectal cancer patients. High IFN-gamma mRNA expression in situ indicated significantly less activation of c-myc mRNA expression. Further, HLA-DR antigen expression in cancer cells, as well as Dukes stages, was an independent factor for better long-term survival by multivariate analysis. Taken together, IFN-gamma, which induces HLA-DR antigens on the cell surface, also suppresses c-myc expression in situ, and is a possible non-immunological mechanism involved in the better long-term survival of colorectal cancer patients.
AuthorsKazuyuki Matsushita, Toshinao Takenouchi, Hideaki Shimada, Takeshi Tomonaga, Hideki Hayashi, Ayumi Shioya, Aki Komatsu, Hisahiro Matsubara, Takenori Ochiai
JournalCancer science (Cancer Sci) Vol. 97 Issue 1 Pg. 57-63 (Jan 2006) ISSN: 1347-9032 [Print] England
PMID16367922 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(Cancer Sci 2006; 97: 57- 63).
Chemical References
  • HLA-DR Antigens
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Interferon-gamma
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Line, Tumor
  • Colorectal Neoplasms (diagnosis, genetics, metabolism, pathology)
  • Epithelium (metabolism, pathology)
  • Female
  • Gene Expression Regulation, Neoplastic
  • HLA-DR Antigens (genetics, metabolism)
  • Humans
  • Interferon-gamma (genetics, metabolism)
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Prognosis
  • Proto-Oncogene Proteins c-myc (genetics, metabolism)
  • RNA, Messenger (genetics)
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: